Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Nantes University Hospital
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Bearer of lung transplantation (single or double lung, with or without associated cardiac transplantation)
Suffering from cystic fibrosis
Aged 18 and over
With at least 6 months of transplantation
Having a glomerular filtration rate measured by technical radionuclide \> 30 ml / min
Having given written consent to the study Patients meeting these criteria will enter in the "organic" in the study (determination of PIIINP urinary)
You may not be if
Lung transplantation for a condition other than cystic fibrosis
Patient refused follow-up
Patients with advanced liver disease (conditions that interfere with the assay of PIIINP)
Minor
Pregnant women,
Major Trust, benefiting from a regime of legal protection (guardianship, trusteeship, safeguarding justice.
Patient unable to grant informed consent.
Clareo Health | Predictive Value of PIIINP Urinary for the Development of Chronic Renal Failure in Patients With Cystic Fibrosis After Lung Transplantation (MUCO-IRC)
